无针注射系统市场报告|份额、增长和规模 2028

  • Report Code : TIPRE00009273
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 252
Buy Now

【研究报告】无针注射系统市场预计将从2021年的1.3164亿美元增长到2028年的4.1131亿美元;预计 2022 年至 2028 年复合年增长率为 17.7%。

市场洞察和分析师观点:

无针注射系统是一种无需使用传统针头即可将药物或疫苗输送到体内的医疗设备。该系统不刺穿皮肤,而是使用高压技术迫使药物穿过皮肤并进入下面的组织。对于害怕针头和注射相关焦虑的患者来说,通常更喜欢这种方法。无针注射系统也用于传统针头可能造成感染或受伤风险的情况。无针注射装置利用压力通过皮肤输送药物,无需传统针头。这可以让患者更加舒适,并降低医疗保健提供者被针刺伤的风险。

对无针注射系统市场产生积极影响的因素是对无针注射系统市场不断增长的需求全球范围内患者的患病率和治疗的推广,增加了对无针注射系统的需求。此外,为了改善无针注射系统市场的医疗保健,技术不断进步,政府举措也不断增加。尽管无针注射装置具有潜在的好处,但一些限制可能会影响市场。一个主要限制是与开发和制造这些设备相关的成本。与传统的基于针的方法相比,无针注射技术的生产更加复杂和昂贵,这可能会限制某些患者和医疗保健提供者的可及性。

增长驱动因素:

无针注射系统的一个主要驱动因素是提高患者的舒适度和依从性。许多患者,尤其是儿童和有针头恐惧症的患者,在面对传统的针头注射时会感到焦虑和恐惧。通过提供无针替代方案,医疗保健提供者可以提高用户/患者的满意度和对治疗计划的依从性。另一个驱动因素是降低医护人员针刺伤和相关污染风险的潜力。针刺伤可能导致严重的健康风险,包括传播艾滋病毒和肝炎等血源性病原体。通过消除对针头的需求,无针注射系统可以帮助保护医护人员免受这些职业危害。

此外,无针注射系统还提供了更精确和更安全的潜力。一致的药物输送。这些系统中的高压技术可以确保药物以正确的深度和正确的力量输送,从而改善治疗效果。总体而言,提高患者舒适度、增强医护人员安全以及优化药物和疫苗输送的愿望推动了无针注射系统的发展。随着技术的进步,无针注射系统的开发和采用预计将在医疗保健行业中增长。

机遇:< /u>

对更方便、侵入性更小的给药方法的需求不断增长,为无针注射市场提供了巨大的机遇。无针注射装置提供了传统注射的无痛且方便的替代方案,使患者更容易坚持其用药方案。这些设备使用喷射注射器或微针等技术,无需针头即可输送药物,为患者提供更舒适的体验。这可以提高药物依从性和患者治疗效果,特别是对于需要频繁注射的慢性疾病。此外,无针注射装置有助于减少针刺伤害和血源性感染传播的机会,使它们成为患者和医疗保健提供者的更安全的选择。随着对更方便、更有效的给药方法的需求不断增长,无针注射市场具有扩大的潜力,并提供创新的解决方案来满足患者和医疗保健提供者的需求。这为医疗保健行业的运营公司提供了一个重要的机会,可以开发和商业化无针注射设备,从而对患者护理和治疗结果产生积极影响。

战略见解

报告细分和范围:

“无针注射系统市场”根据类型、产品、技术、可用性、交付地点、应用程序、最终用户和地理位置进行细分。根据类型,市场分为液体无针注射器、弹丸/储库型无针注射器、粉末无针注射器。就产品而言,无针注射系统市场分为可填充无针注射器、预填充无针注射器。根据技术,市场分为喷射式无针注射器、弹簧全局无针注射器、激光驱动无针注射器、振动式无针注射器。根据可用性,市场分为一次性无针注射器、可重复使用无针注射器。根据注射部位,市场分为皮下注射器、肌肉注射器、皮内注射器。在应用方面,无针注射系统市场细分为疫苗输送、胰岛素输送、肿瘤学、疼痛管理等。根据最终用户,市场分为医院和诊所、家庭护理机构、研究实验室、制药和生物技术公司等。无针注射系统市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。    

细分分析:

根据类型,市场分为液基无针注射器、弹丸/储库型无针注射器和粉剂无针注射器。液基无针注射器细分市场在 2022 年占据最大市场份额,预计 2022-2030 年市场复合年增长率最高。液基无针注射市场的主要驱动力之一是对更方便、更少痛苦的给药方法的需求不断增长。患者越来越多地寻找传统针注射的替代方案,而基于液体的无针注射系统提供了更舒适、侵入性更小的选择。另一个驱动因素是改善药物依从性和患者治疗结果的潜力。液基无针注射系统可以提供更精确和一致的药物输送,提高治疗效果和患者满意度。

此外,慢性病发病率和患病率不断上升,定期用药的需求推动了对更加用户友好的注射方法的需求。液体无针注射系统可以帮助患者和医疗保健提供者更有效地管理慢性病。此外,对降低医疗成本和提高效率的关注推动了基于液体的无针注射系统的采用。这些系统可以帮助最大限度地降低针刺伤害的风险和相关的医疗费用,并减少对一次性针头和注射器的需求。总体而言,液基无针注射市场的推动因素是对更方便、安全和有效的药物剂量输送方法的渴望,以及改善患者治疗效果和降低医疗成本的需求。因此,这些系统的市场预计在未来几年将继续增长。

无针注射系统市场(按类型) 2022年和2030年

区域分析:

根据地理位置,无针注射系统市场分为五个主要区域:北美、欧洲、亚太地区、南美&中美洲、中东和非洲非洲。到 2022 年,北美可能会占据全球无针注射系统市场的重要份额。该地区的市场增长归因于对微创手术的需求不断增长、技术进步不断进步以及对患者安全的日益关注。糖尿病、高血压和哮喘等慢性病的发病率和患病率较高,导致对定期用药的需求更大。其中许多疾病需要每天或频繁服用药物来控制症状并预防并发症。因此,对更方便、侵入性更小的给药方法的需求不断增长,使患者更容易遵守规定的治疗方案。传统的药物剂量输送方法,例如口服片剂或注射剂,对患者来说既麻烦又痛苦,导致依从性差和治疗结果不佳。因此,需要创新的给药技术,为患者提供更方便、舒适的体验。

此外,慢性病的增加也带来了负担医疗保健系统和资源,导致重点关注降低医疗保健成本和提高效率。通过更有效的药物输送方法提高药物依从性和患者治疗效果,医疗保健提供者可以减轻各种慢性疾病的负担并降低总体医疗成本。总体而言,慢性病患病率的不断上升和定期用药的需求,对更方便、安全和有效的给药方法产生了强烈需求,例如无针注射系统,可以提高患者的依从性和治疗效果。这些是北美国家(包括美国、加拿大和墨西哥)增加无针注射系统使用的主要因素。

此外,约有 140 万糖尿病病例在美国每年都会被诊断出来。根据美国疾病控制与预防中心的数据,2020 年,约 8800 万成年人患有糖尿病前期,占美国成年人口的 34.5%。据加拿大糖尿病协会称,到 2022 年,该国糖尿病患病率将不断上升,报告的糖尿病或糖尿病前期病例将达到 1170 万例。据同一消息来源称,约 570 万加拿大人患有糖尿病。根据加拿大统计局的数据,加拿大的生育率较低,从 2019 年的每名妇女 1.47 个孩子下降到 2020 年的每名妇女 1.40 个孩子。根据加拿大健康信息研究所的数据,2022 年 7 月,约 240 万人被诊断患有心脏病。这是加拿大继癌症之后的第二大死亡原因。过去几年,为了减轻与多种慢性疾病相关的负担,对微创手术的需求显着增加。    

行业发展及未来机遇:

全球无针注射系统市场主要参与者采取的各种举措如下:

  1. 2023年11月,美光生物医学获得资金生产无针疫苗。该疫苗注射起来无痛,通过将微阵列技术应用于皮肤并按下按钮进行注射来发挥作用。
  2. 2022 年 6 月,NovaXS 推出了其专利“Telosis 技术”。 0.3 秒内无需针头即可给药,从而做出更明智的健康决策。
  3. 2022 年 12 月,Prejex Inc. 宣布与 Polybond 达成协议,生产无针注射剂。< li>2020年11月,领先的无针注射设备制造商PharmaJet宣布与全球制药公司Mundipharma建立战略合作伙伴关系。此次合作旨在扩大 PharmaJet 无针注射技术在疫苗和药物管理方面的可用性。

竞争格局和主要公司:

PharmaJet、Portal Instruments、Medical International Technology, Inc.、NuGen Medical Devices、Crossject SA、Antares Pharma、3M、Injex Pharma AG、NovaXS Biotech、INVIO Pharmaceutical Inc. 是主要的无针注射系统公司。这些公司专注于新技术、现有产品的进步以及地域扩张,以满足全球不断增长的消费者需求。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is projected to be the fastest-growing region in the global needle free injection system market?

The Asia Pacific is expected to be the fastest-growing region in the needle free injection system market over the forecast period due to growing investments from international players in China and India, improving government support in countries, collaboration of research organizations, and advancing healthcare infrastructure.

What are the driving factors for the global needle free injection system market across the world?

The factors that are driving the growth of the needle free injection system market are increasing incidence of communicable diseases due to needlestick injuries and rising demand for self-injection devices are the major factors contributing to the growth of the Needle Free Injection System industry.

What are the growth estimates for the needle free injection system market till 2028?

The needle free injection system market is expected to be valued at US$ 411,312.81 thousands in 2028.

Which segment by product led the needle free injection system market?

The fillable needle-free injectors segment held the largest share of the market in the global needle free injection system market contributing a market share of 63.6% in 2021.

What are needle free injection system?

Needle-free injection system is a jet injector that delivers medicine to intramuscular and subcutaneous tissue depths without needles. Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, advantages of drug delivery technology, increasing demand for self-injection devices.

What is the estimated needle free injection system market size in 2021?

The Needle Free Injection System market is estimated to be valued at US$ 131,640.54 thousands in 2021.

What is the market CAGR value of the needle free injection system market during the forecast period?

The CAGR value of the needle free injection system market during the forecasted period of 2022-2028 is 17.7%

Who are the major players in the needle free injection system market across the globe?

The Needle Free Injection System market majorly consists of the players, such as Crossject; INOVIO Pharmaceuticals; Zealand Pharma A/S; PharmaJet; Portal Instruments; Medical International Technologies (MIT Canada) Inc.; NuGen Medical Devices; Ferring B.V.; National Medical Products, Inc.; and Aijex Pharma International Inc. among others.

The List of Companies - Needle Free Injector System Market

  1. Crossject                
  2. INOVIO Pharmaceuticals                  
  3. Zealand Pharma A/S          
  4. PharmaJet             
  5. Portal Instruments             
  6. Medical International Technologies (MIT Canada) Inc.         
  7. NuGen Medical Devices    
  8. Ferring B.V.           
  9. National Medical Products, Inc.     
  10. Aijex Pharma International Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports